|
1
|
Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips.
|
J Cyclic Nucleotide Res
|
1982
|
2.63
|
|
2
|
Evidence for cyclic GMP-mediated relaxant effects of nitro-compounds in coronary smooth muscle.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1979
|
1.95
|
|
3
|
Minimal effects of levosimendan on coronary artery smooth muscle tone.
|
Cardiovasc Drugs Ther
|
1999
|
1.39
|
|
4
|
Study of long-term percutaneous toxicity and carcinogenicity of hair dyes (oxidizing dyes) in rats.
|
Food Cosmet Toxicol
|
1973
|
1.24
|
|
5
|
Anandamide-induced mobilization of cytosolic Ca2+ in endothelial cells.
|
Br J Pharmacol
|
1999
|
1.14
|
|
6
|
Quantitative estimation of overadditive and underadditive drug effects by means of theoretical, additive dose-response curves.
|
J Pharmacol Methods
|
1980
|
1.11
|
|
7
|
Role of cyclic nucleotides in adenosine-mediated regulation of coronary flow.
|
Adv Cyclic Nucleotide Res
|
1978
|
1.09
|
|
8
|
Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75).
|
J Cardiovasc Pharmacol
|
1983
|
1.08
|
|
9
|
Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution.
|
Diabetes
|
1999
|
0.96
|
|
10
|
Molecular mechanism of action of nicorandil.
|
J Cardiovasc Pharmacol
|
1992
|
0.95
|
|
11
|
Prostacyclin increases cAMP in coronary arteries.
|
J Cyclic Nucleotide Res
|
1979
|
0.94
|
|
12
|
Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
|
J Cardiovasc Pharmacol
|
1989
|
0.94
|
|
13
|
Evaluation of combined effects in dose-response studies by statistical comparison with additive and independent interactions.
|
J Pharmacol Methods
|
1990
|
0.93
|
|
14
|
Mechanism of nitrate-induced vasodilation and tolerance.
|
Z Kardiol
|
1983
|
0.92
|
|
15
|
Mode of action of coronary arterial relaxation by prostacyclin.
|
J Cyclic Nucleotide Res
|
1980
|
0.91
|
|
16
|
Mode of action of nitrates with regard to vasodilatation and tolerance.
|
Z Kardiol
|
1986
|
0.89
|
|
17
|
Function of cyclic GMP in acetylcholine-induced contraction of coronary smooth muscle.
|
Naunyn Schmiedebergs Arch Pharmacol
|
1982
|
0.86
|
|
18
|
Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization.
|
J Cardiovasc Pharmacol
|
1991
|
0.86
|
|
19
|
Cyclic GMP in nicorandil-induced vasodilatation and tolerance development.
|
J Cardiovasc Pharmacol
|
1987
|
0.83
|
|
20
|
Potentiation of Ca2+ signaling in endothelial cells by 11,12-epoxyeicosatrienoic acid.
|
J Cardiovasc Pharmacol
|
1999
|
0.83
|
|
21
|
Mechanisms of L-NG nitroarginine/indomethacin-resistant relaxation in bovine and porcine coronary arteries.
|
Br J Pharmacol
|
1996
|
0.83
|
|
22
|
Mechanism of vasodilation by molsidomine.
|
Am Heart J
|
1985
|
0.83
|
|
23
|
Cellular mechanisms of action of therapeutic nitric oxide donors.
|
Eur Heart J
|
1991
|
0.81
|
|
24
|
Cyclic GMP as the mediator of molsidomine-induced vasodilatation.
|
Eur J Pharmacol
|
1986
|
0.81
|
|
25
|
Mechanisms of nitrate-induced vasodilatation and tolerance on a biochemical base.
|
Z Kardiol
|
1985
|
0.80
|
|
26
|
Lack of second messenger function of cyclic GMP in acetylcholine-induced negative inotropism.
|
J Cardiovasc Pharmacol
|
1987
|
0.80
|
|
27
|
In human hypercholesterolemia increased reactivity of vascular smooth muscle cells is due to altered subcellular Ca(2+) distribution.
|
Atherosclerosis
|
2000
|
0.79
|
|
28
|
Effect of papaverine on cyclic AMP, calcium uptake and force of contraction in isolated guinea-pig auricles.
|
Res Commun Chem Pathol Pharmacol
|
1977
|
0.78
|
|
29
|
Mechanisms of nitrate-induced vasodilatation and tolerance.
|
Eur J Clin Pharmacol
|
1990
|
0.78
|
|
30
|
Overadditive synergism between theophylline, diprophylline and proxyphylline in tracheal smooth muscle relaxation.
|
Arzneimittelforschung
|
1983
|
0.76
|
|
31
|
[Role of cyclic AMP in coronary circulation].
|
Med Welt
|
1974
|
0.75
|
|
32
|
[Interventional electrophysiology in cardiac MRI : what is the current status?].
|
Herz
|
2012
|
0.75
|
|
33
|
[ACE inhibitors with SH groups have no effect of ATP-dependent K channels--a dissertation].
|
Acta Med Austriaca
|
1996
|
0.75
|
|
34
|
Evaluation and interpretation of dose response experiments with decreased baseline.
|
Methods Find Exp Clin Pharmacol
|
1983
|
0.75
|
|
35
|
[Contrast effect and tissue tolerance of radiopaque thread].
|
Chirurg
|
1969
|
0.75
|
|
36
|
[Mechanism of the vasodilating effect and blood platelet- antiaggregating activity of molsidomine and SIN-1].
|
Pathol Biol (Paris)
|
1987
|
0.75
|
|
37
|
[A method of comparison between a woven cellulose wool material and a metallic fleece substance in reference to its wound-affecting properties].
|
Chirurg
|
1965
|
0.75
|
|
38
|
KATP channel opening does not contribute significantly to the vasodilatory effect of SH-group-containing ACE inhibitors.
|
Heart Vessels
|
1996
|
0.75
|
|
39
|
[Phosphodiesterase inhibition as the action mechanism of various coronary vasodilator agents].
|
Hoppe Seylers Z Physiol Chem
|
1972
|
0.75
|
|
40
|
[Pharmacological Properties of Fendiline in Cardiac and Smooth Muscle (author's transl)].
|
Arzneimittelforschung
|
1976
|
0.75
|
|
41
|
EDRF does not mediate coronary vasodilation secondary to simulated ischemia: a study on KATP channels and N omega-nitro-L-arginine on coronary perfusion pressure in isolated Langendorff-perfused guinea-pig hearts.
|
Cardiovasc Drugs Ther
|
1998
|
0.75
|
|
42
|
Mechanism of vasodilation by nitrates: role of cyclic GMP.
|
Cardiology
|
1987
|
0.75
|
|
43
|
[The mechanism of action of bencyclane on smooth musculature].
|
Arzneimittelforschung
|
1975
|
0.75
|